Patriot Financial Group Insurance Agency’s Dr. Reddy's Laboratories RDY Stock Holding History

Patriot Financial Group Insurance Agency’s Portfolio RDY Stock Details RDY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-420	Closed	-$5K	–	1591
2022 Q2	$5K	Sell	420 -460	-52%	-$5K	﹤0.01%	1497
2022 Q1	$10K	Buy	880 +400	+83%	+$4.54K	﹤0.01%	1373
2021 Q4	$6K	Sell	480 -155	-24%	-$1.95K	﹤0.01%	1662
2021 Q3	$8K	Hold	635	–	–	﹤0.01%	1570
2021 Q2	$9K	Buy	635 +155	+32%	+$2.17K	﹤0.01%	1489
2021 Q1	$6K	Hold	480	–	–	﹤0.01%	1509
2020 Q4	$7K	Hold	480	–	–	﹤0.01%	1333
2020 Q3	$7K	Buy	480 +100	+26%	+$1.19K	﹤0.01%	1146
2020 Q2	$4K	Sell	380 -25	-6%	-$254	﹤0.01%	1257
2020 Q1	$3K	Buy	+405	New	+$3.38K	﹤0.01%	1238

Other funds holding RDY

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Patriot Financial Group Insurance Agency's RDY Position: Q3 2022 in Review

Patriot Financial Group Insurance Agency sold out of Dr. Reddy's Laboratories (RDY) in Q3 2022, closing a stake of 420 shares — an estimated $5K sold.

Patriot Financial Group Insurance Agency first reported a position in RDY in Q1 2020 and held it in 10 quarters. The position peaked at $10K in Q1 2022. 151 funds tracked by Wall St. Rank hold RDY as of Q3 2022.

Patriot Financial Group Insurance Agency reported no remaining Dr. Reddy's Laboratories position as of Q3 2022 after selling out during the quarter.
Patriot Financial Group Insurance Agency sold 420 Dr. Reddy's Laboratories shares in Q3 2022, an estimated $5K.
Patriot Financial Group Insurance Agency first reported a position in Dr. Reddy's Laboratories in Q1 2020 and held it in 10 quarters.
Patriot Financial Group Insurance Agency's Dr. Reddy's Laboratories position peaked at $10K in Q1 2022.
151 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q3 2022.

Based on Patriot Financial Group Insurance Agency's 13F filing for Q3 2022, filed 1 Nov 2022.